These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 4742736)

  • 21. Blockade of acetylcholine receptors: a model of myasthenia gravis.
    Satyamurti S; Drachman DB; Slone F
    Science; 1975 Mar; 187(4180):955-7. PubMed ID: 1145181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of decremental response in decentralized muscles of a myasthenic patient.
    Fiacchino F; Crenna P; Sghirlanzoni A; Peluchetti D; Allegranza A
    Ital J Neurol Sci; 1983 Sep; 4(3):355-7. PubMed ID: 6315636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody.
    Punga AR; Flink R; Askmark H; Stålberg EV
    Muscle Nerve; 2006 Jul; 34(1):111-5. PubMed ID: 16453324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Congenital canine myasthenia gravis: I. Deficient junctional acetylcholine receptors.
    Oda K; Lambert EH; Lennon VA; Palmer AC
    Muscle Nerve; 1984; 7(9):705-16. PubMed ID: 6543919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How the autoimmune response to acetylcholine receptor impairs neuromuscular transmission in myasthenia gravis and its animal model.
    Lindstrom J
    Fed Proc; 1978 Dec; 37(14):2828-30. PubMed ID: 214352
    [No Abstract]   [Full Text] [Related]  

  • 26. Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins.
    Appel SH; Anwyl R; McAdams MW; Elias S
    Proc Natl Acad Sci U S A; 1977 May; 74(5):2130-4. PubMed ID: 266734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incrementing responses in myasthenia gravis.
    Mayer RF; Williams IR
    Arch Neurol; 1974 Jul; 31(1):24-6. PubMed ID: 4365402
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pathophysiology of myasthenia gravis and the myasthenic syndrome].
    Struppler A; Ruprecht EO
    Anaesthesist; 1971 Jan; 20(1):29-35. PubMed ID: 4322997
    [No Abstract]   [Full Text] [Related]  

  • 29. Passive transfer of seronegative myasthenia gravis to mice.
    Burges J; Vincent A; Molenaar PC; Newsom-Davis J; Peers C; Wray D
    Muscle Nerve; 1994 Dec; 17(12):1393-400. PubMed ID: 7969240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between anti-acetylcholine receptor antibody levels and neuromuscular function in chronically myasthenic rats.
    Gallant PE
    J Neurol Sci; 1982 Apr; 54(1):129-41. PubMed ID: 6281392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Andreis I; Lovnićki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myasthenia gravis: a serum factor blocking acetylcholine receptors of the human neuromuscular junction.
    Bender AN; Ringel SP; Engel WK; Daniels MP; Vogel Z
    Lancet; 1975 Mar; 1(7907):607-9. PubMed ID: 47950
    [No Abstract]   [Full Text] [Related]  

  • 33. Neuromuscular defect after suppression of ion conductance.
    Takamori M; Ide Y; Kasai M
    Neurology; 1979 Jun; 29(6):772-9. PubMed ID: 221854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single fibre electromyographic studies in myasthenia gravis with repetitive nerve stimulation.
    Schwartz MS; Stålberg E
    J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):678-82. PubMed ID: 1159439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myasthenia gravis animal model: quantitative analysis of the efficiency of pre- and postjunctional regions of intercostal muscles in rabbits immunized with Torpedo acetylcholine receptor.
    Albuquerque EX; Eldefrawi AT; Oliveira AC; Copio DS; Eldefrawi ME
    Exp Neurol; 1979 Oct; 66(1):109-22. PubMed ID: 225189
    [No Abstract]   [Full Text] [Related]  

  • 36. Experimental myasthenia due to alpha-bungarotoxin.
    Takamori M; Iwanaga S
    Neurology; 1976 Sep; 26(9):844-8. PubMed ID: 181695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunopathology of myasthenia gravis.
    Drachman DB
    Fed Proc; 1979 Nov; 38(12):2613-5. PubMed ID: 227751
    [No Abstract]   [Full Text] [Related]  

  • 38. Homeostatic synaptic plasticity at the neuromuscular junction in myasthenia gravis.
    Wang X; Rich MM
    Ann N Y Acad Sci; 2018 Jan; 1412(1):170-177. PubMed ID: 28981978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody to acetylcholine receptor increases degradation of junctional and extrajunctional receptors in adult muscle.
    Reiness CG; Weinberg CB; Hall ZW
    Nature; 1978 Jul; 274(5666):68-70. PubMed ID: 661996
    [No Abstract]   [Full Text] [Related]  

  • 40. Myasthenia gravis: passive transfer from man to mouse.
    Toyka KV; Brachman DB; Pestronk A; Kao I
    Science; 1975 Oct; 190(4212):397-9. PubMed ID: 1179220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.